KERN: AI 评分 43/100 — AI 分析 (4月 2026)

Akerna Corp. provides enterprise software solutions for regulatory compliance and inventory management in the cannabis, hemp, and CBD industries. The company's MJ Platform and Leaf Data Systems offer tracking, reporting, and compliance tools to cultivators, processors, sellers, and government regulatory bodies.

Key Facts: Price: $0.31 AI Score: 43/100 Sector: Healthcare

公司概况

概要：

Akerna Corp. is a leading provider of compliance and inventory management software for the cannabis industry, offering a comprehensive seed-to-sale platform and data analytics solutions, positioning it to capitalize on the expanding legal cannabis market in the US and Canada.

KERN是做什么的？

Founded in 2010 and headquartered in Denver, Colorado, Akerna Corp. emerged as a key player in the burgeoning cannabis industry by providing essential software solutions. Recognizing the complex regulatory landscape and the need for efficient inventory management, Akerna developed the MJ Platform, a comprehensive seed-to-sale platform designed for cannabis, hemp, and CBD businesses. This platform offers tracking, reporting, and compliance tools crucial for cultivators, processors, sellers, and clinics. Akerna's commitment extends beyond commercial enterprises, as evidenced by Leaf Data Systems, a government regulatory software solution. This offering underscores Akerna's dedication to supporting regulatory compliance at all levels. The company further enhances its value proposition through consulting services tailored to the cannabis industry, along with business intelligence, data analytics, and other software-related services. Akerna also provides Last Call Analytics, a tool designed for alcohol brands to analyze their retail sales data. Akerna's comprehensive suite of solutions positions it as a vital partner for businesses navigating the complexities of the cannabis and related industries.

KERN的投资论点是什么？

Akerna presents a notable market position due to its strategic positioning within the rapidly expanding legal cannabis market. The company's comprehensive seed-to-sale platform, coupled with its government regulatory software, provides a unique value proposition in a highly regulated industry. With a gross margin of 42.4%, Akerna demonstrates its ability to generate profitability from its software solutions. The increasing legalization of cannabis across North America serves as a significant growth catalyst, driving demand for Akerna's compliance and inventory management tools. While the company's negative P/E ratio of -15.93 and negative profit margin of -22.8% indicate current challenges, the potential for revenue growth in a burgeoning market, combined with operational efficiencies, could lead to improved financial performance and increased shareholder value.

KERN在哪个行业运营？

Akerna operates within the medical and healthcare information services sector, specifically catering to the cannabis industry. The legal cannabis market is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. This growth necessitates robust compliance and inventory management solutions, creating a significant demand for Akerna's offerings. The competitive landscape includes companies like ATLN (Atlantic Coastal Healthcare Acquisition Corp), BLPH (BioLineRx Ltd), CMAX (CareMax Inc), HSTO (Histogen Inc), and HUGE (FSD Pharma Inc), some of which offer overlapping or complementary services. Akerna differentiates itself through its comprehensive seed-to-sale platform and government regulatory software.

Medical - Healthcare Information Services

Healthcare

KERN有哪些增长机遇？

Expansion into New Geographies: As more states and countries legalize cannabis, Akerna has the opportunity to expand its operations into new markets. This expansion can be achieved through direct sales, partnerships, or acquisitions. The global legal cannabis market is projected to reach billions of dollars in the coming years, providing a substantial growth runway for Akerna.
Product Innovation and Development: Akerna can further enhance its product offerings by developing new features and functionalities for its MJ Platform and Leaf Data Systems. This includes incorporating advanced analytics, artificial intelligence, and machine learning to provide more insights and automation for its customers. Continuous innovation will help Akerna maintain its competitive edge and attract new customers.
Strategic Partnerships and Acquisitions: Akerna can pursue strategic partnerships and acquisitions to expand its product portfolio, geographic reach, and customer base. This includes partnering with other technology providers, cannabis industry consultants, and regulatory experts. Acquisitions can provide access to new technologies, markets, and talent.
Increased Focus on Data Analytics: Akerna can leverage its vast data resources to provide valuable insights and analytics to its customers. This includes offering customized reports, benchmarking data, and predictive analytics to help cannabis businesses optimize their operations, improve compliance, and increase profitability. Data analytics can become a significant revenue stream for Akerna.
Penetration of the Hemp and CBD Market: While Akerna has a presence in the hemp and CBD market, there is significant opportunity to further penetrate this segment. The hemp and CBD market is experiencing rapid growth, driven by increasing consumer awareness and demand for these products. Akerna can tailor its solutions to meet the specific needs of hemp and CBD businesses, capturing a larger share of this market.

Akerna operates in the rapidly growing cannabis, hemp, and CBD industry, poised for expansion as legalization efforts continue.
The company's MJ Platform offers a comprehensive seed-to-sale solution, addressing critical compliance and inventory management needs.
Leaf Data Systems provides government regulatory software, demonstrating Akerna's commitment to supporting regulatory compliance.
Akerna's gross margin of 42.4% indicates a strong ability to generate profit from its software solutions.
The company's beta of 2.79 suggests higher volatility compared to the overall market, reflecting the growth potential and risk associated with the cannabis industry.

KERN提供哪些产品和服务？

Provides seed-to-sale tracking software for the cannabis industry.
Offers regulatory compliance solutions for cannabis businesses.
Develops inventory management systems for cannabis cultivators, processors, and retailers.
Provides data analytics and business intelligence tools.
Offers consulting services to cannabis businesses.
Develops government regulatory software for cannabis tracking.
Provides solutions for the hemp and CBD industry.
Offers retail sales analytics for alcohol brands.

KERN如何赚钱？

Software as a Service (SaaS): Akerna generates revenue through recurring subscription fees for its MJ Platform and Leaf Data Systems.
Consulting Services: The company earns revenue from providing consulting services to cannabis businesses.
Data Analytics: Akerna generates revenue from providing data analytics and business intelligence services.
Software Related Services: The company earns revenue from other software related services.

Cannabis cultivators
Cannabis processors
Cannabis retailers
Cannabis clinics
Government regulatory bodies

Comprehensive Seed-to-Sale Platform: Akerna's MJ Platform offers a complete solution for tracking cannabis products from seed to sale, providing a competitive advantage over point solutions.
Regulatory Expertise: The company's deep understanding of cannabis regulations and its Leaf Data Systems software provide a barrier to entry for competitors.
Established Customer Base: Akerna has an established customer base in the cannabis industry, providing a recurring revenue stream and a competitive advantage.
Data Analytics Capabilities: Akerna's data analytics capabilities provide valuable insights to its customers, differentiating it from competitors.

什么因素可能推动KERN股价上涨？

Upcoming: Further legalization of cannabis in additional states and countries, driving demand for compliance software.
Ongoing: Expansion of Akerna's product offerings to include new features and functionalities.
Ongoing: Strategic partnerships and acquisitions to expand market reach and product portfolio.

KERN的主要风险是什么？

Potential: Increasing competition in the cannabis software market, potentially leading to price pressure.
Potential: Changes in cannabis regulations, requiring Akerna to adapt its software and services.
Potential: Economic downturn impacting cannabis businesses, reducing demand for Akerna's solutions.
Ongoing: Cybersecurity risks, potentially compromising customer data and disrupting operations.

KERN的核心优势是什么？

Comprehensive seed-to-sale platform
Regulatory expertise and government software
Established customer base in the cannabis industry
Data analytics capabilities

KERN的劣势是什么？

Negative P/E ratio and profit margin
High beta indicating volatility
Dependence on the cannabis industry
Limited geographic diversification

KERN有哪些机遇？

Expansion into new geographic markets
Product innovation and development
Strategic partnerships and acquisitions
Increased focus on data analytics

KERN面临哪些威胁？

Increasing competition in the cannabis software market
Changing cannabis regulations
Economic downturn impacting cannabis businesses
Cybersecurity risks

KERN的竞争对手是谁？

Atlantic Coastal Healthcare Acquisition Corp — Acquisition company, may enter the cannabis space. — (ATLN)
BioLineRx Ltd — Biopharmaceutical company with potential overlap in cannabis-related therapeutics. — (BLPH)
CareMax Inc — Focuses on value-based care, potentially overlapping in the medical cannabis space. — (CMAX)
Histogen Inc — Regenerative medicine company, limited direct competition. — (HSTO)
FSD Pharma Inc — Cannabis-focused pharmaceutical company, direct competitor in certain areas. — (HUGE)

Key Metrics

Price: $0.31 (+36.94%)
MoonshotScore: 43/100

Company Profile

CEO: Jessica Billingsley
Headquarters: Denver, CO, US
Employees: 112
Founded: 2018

AI Insight

常见问题

What does Akerna Corp. do?

Akerna Corp. provides enterprise software solutions tailored for the cannabis, hemp, and CBD industries. Its core offering, the MJ Platform, is a comprehensive seed-to-sale platform that enables regulatory compliance and efficient inventory management for cultivators, processors, and retailers. Additionally, Akerna develops and supports Leaf Data Systems, a government regulatory software used for cannabis tracking and compliance. Beyond software, Akerna offers consulting services and data analytics to help cannabis businesses optimize their operations and navigate the complex regulatory landscape, positioning itself as a key enabler for the legal cannabis market.

Is KERN stock a good buy?

KERN stock presents a speculative investment opportunity within the high-growth cannabis industry. While the company's negative P/E ratio of -15.93 and negative profit margin of -22.8% raise concerns, its 42.4% gross margin suggests potential for profitability as the market expands and the company achieves scale. The increasing legalization of cannabis serves as a major growth catalyst, driving demand for Akerna's compliance solutions. Investors should carefully weigh the risks and potential rewards, considering the company's financial performance, competitive landscape, and regulatory environment before investing.

What are the main risks for KERN?

Akerna faces several key risks, including increasing competition in the cannabis software market, which could lead to price erosion and market share loss. Changes in cannabis regulations could require costly and time-consuming software updates to maintain compliance. An economic downturn could negatively impact cannabis businesses, reducing demand for Akerna's solutions. Furthermore, cybersecurity risks pose a threat to customer data and operational stability. The company's high beta of 2.79 indicates significant volatility, reflecting the inherent risks associated with the cannabis industry and Akerna's growth trajectory.